Wen Tan
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Oncology top 1%
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Topics
- RNA modifications and cancer (24 papers)DNA Repair Mechanisms (21 papers)Epigenetics and DNA Methylation (18 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wen Tan
122 papers receiving 6.2k citations
Peers
Comparison fields: 5 of 140
- Molecular Biology 3.9k
- Cancer Research 2.1k
- Oncology 1.8k
- Surgery 773
- Pulmonary and Respiratory Medicine 747
Countries citing papers authored by Wen Tan
This map shows the geographic impact of Wen Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Tan more than expected).
Fields of papers citing papers by Wen Tan
This network shows the impact of papers produced by Wen Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Tan. The network helps show where Wen Tan may publish in the future.
Co-authorship network of co-authors of Wen Tan
This figure shows the co-authorship network connecting the top 25 collaborators of Wen Tan. A scholar is included among the top collaborators of Wen Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Tan. Wen Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 23 | |
| 3 | 5 | |
| 4 | 56 | |
| 5 | 1 | |
| 6 | 27 | |
| 7 | [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism]. | 2 |
| 8 | 10 | |
| 9 | 60 | |
| 10 | 39 | |
| 11 | 114 | |
| 12 | 36 | |
| 13 | 15 | |
| 14 | 104 | |
| 15 | 44 | |
| 16 | 138 | |
| 17 | 21 | |
| 18 | 218 | |
| 19 | 91 | |
| 20 | 97 |
About Wen Tan
Wen Tan is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 125 papers that have together received 6.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (24 papers), DNA Repair Mechanisms (21 papers) and Epigenetics and DNA Methylation (18 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (1.8k citations) and Molecular Biology (3.9k citations). Wen Tan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Dongxin Lin, Xiaoping Miao, Dianke Yu, Chen Wu, Xuemei Zhang, Ming Yang, Deyin Xing, Yifeng Zhou, Chun-Yuan Yu and Yongli Guo. Their work appears in journals such as Nature Communications, Nature Genetics and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.